Chemokine Receptors in Vascular Smooth Muscle

REFERENCES

• Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. (2000). The stromal cell-derived fac-tor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86: 131–138.
   PubMed Web of Science ®Google Scholar
• Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM. (1999). Monocyte chemoattrac-tant protein-1 accelerates atherosclerosis in apolipo-protein E-deficient mice. Arterioscler Thromb Vasc Biol 19:1518–1525.
   PubMed Web of Science ®Google Scholar
• Alexander RW, Brock TA, Gimbrone MA Jr, Ritten-house SE. (1985). Angiotensin increases inositol tris-phosphate and calcium in vascular smooth muscle. Hypertension 7:447–451.
   Google Scholar
• Berger O, Gan X, Gujuluva C, Burns AR, Sulur G, Stins M, Way D, Witte M, Weinand M, Said J, Kim KS, Taub D, Graves MC, Fiala M. (1999). CXC and CC chemokine receptors on coronary and brain en-dothelia. Mol Med 5:795–805.
   PubMed Web of Science ®Google Scholar
• Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, Parmentier M. (1999). CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94:1899–1905.
   PubMed Web of Science ®Google Scholar
• Boring L, Gosling J, Cleary M, Charo IF. (1998). De-creased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclero-sis. Nature 394:894–897.
   PubMed Web of Science ®Google Scholar
• Carrozza JP Jr, Schatz RA, George CJ, Leon MB, King SB 3rd, Hirshfeld JW, Curry RC Jr, Ivanhoe RJ, Buch-binder M, Cleman MW, Goldberg S, Ricci D, Popma JJ, Safian RD, Baim DS. (1997). Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol 80:78K–88K.
   Google Scholar
• Charo Fl, Myers JS, Herman A, Franci C, Connolly JA, Coughlin RS. (1994). Molecular cloning and functional expression of two monocyte chemoattrac-tant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Nall Acad Sci USA 91:2752–2756.
   PubMed Web of Science ®Google Scholar
• Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P. Chiarelli F, Cuccurullo F, Mezzetti A. (2001). El-evated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21 :327–334.
   PubMed Web of Science ®Google Scholar
• Clowes AW, Clowes MM, Fingerle J, Reidy MA. (1989). Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 14:S12–S15.
   Google Scholar
• Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. (1996). Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. JLeukoc Biol 60:147–152.
   PubMed Web of Science ®Google Scholar
• Cushing SD, Berliner JA, Valente AJ, Territo MC, Na-vab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. (1990). Minimally modified low density lipopro-tein induces monocyte chemotactic protein 1 in hu-man endothelial cells and smooth muscle cells. Proc Nall Acad Sci USA 87:5134–5138.
   PubMed Web of Science ®Google Scholar
• De Keulenaer GW, Ushio-Fukai M, Yin Q, Chung AB, Lyons PR, Ishizaka N, Rengarajan K, Taylor WR, Alexander RW, Griendling KK. (2000). Convergence of redox-sensitive and mitogen-activated protein ki-nase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterio-scler Thromb Vasc Biol 20:385–391.
   PubMed Web of Science ®Google Scholar
• Denger S, Jahn L, Wende P, Watson L, Gerber SH, Kubler W, Kreuzer J. (1999). Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis 144:15–23.
   Google Scholar
• Doms RW. (2000). Beyond receptor expression: the influence of receptor conformation, density, and af-finity in HIV-1 infection. Virology 276:229–237.
   PubMed Web of Science ®Google Scholar
• Dragic T, Litwin V. Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673.
   PubMed Web of Science ®Google Scholar
• Feng Y, Broder CC, Kennedy PE, Berger EA. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872–877.
   PubMed Web of Science ®Google Scholar
• Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an anti-body to PDGF. Science 253:1129–1132.
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S. (1999). Anti-monocyte chemoattractant protein-1 /monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 84:306–314.
   PubMed Web of Science ®Google Scholar
• Galli M, Ridolfo AL, Gervasoni C. (2001). Cardiovas-cular disease risk factors in HIV-infected patients in the HAART era. Ann N YAcad Sci 946:200–213.
   PubMedGoogle Scholar
• Gerard C, Rollins BJ. (2001). Chemokines and dis-ease. Nat Immunol 2:108–115.
   PubMed Web of Science ®Google Scholar
• Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. (1998). Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275–281.
   PubMed Web of Science ®Google Scholar
• Gujuluva C, Burns AR, Pushkarsky T, Popik W, Berger O, Bukrinsky M, Graves MC, Fiala M. (2001). HIV-1 penetrates coronary artery endothelial cells by transcytosis. Mol Med 7:169–176.
   PubMedGoogle Scholar
• Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, Roach AG, Westwick J, Williams RJ. (1998). Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol 18:397–403.
   Google Scholar
• Herbein G, Mahlknecht U, Batliwalla F, Gregersen P. Pappas T, Butler J, O'Brien WA, Verdin E. (1998). Apoptosis of CD8+ T cells is mediated by macro-phages through interaction of HIV gp120 with che-mokine receptor CXCR4. Nature 395:189–194.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kel-sey SF, Detre KM, et al. (1984). Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the Na-tional Heart, Lung, and Blood Institute. Am J Cardiol 53:77C–81C.
   Google Scholar
• Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, Shimada K. (1993). Expression of inter-cellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Athero-sclerosis 104:61–68.
   Google Scholar
• Ikeda U, Okada K, Ishikawa S, Saito T, Kasahara T, Shimada K. (1995). Monocyte chemoattractant pro-tein 1 inhibits growth of rat vascular smooth muscle cells. Am J Physiol 268:H1021–H1026.
   Google Scholar
• Kirchhofer D, Nemerson Y. (1996). Initiation of blood coagulation: the tissue factor/factor Vila com-plex. Curr Opin Biotechnol 7:386–391.
   PubMedGoogle Scholar
• Lewis W. (2000). Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV. J Mol Cell Cardiol 32:2115–2129.
   PubMed Web of Science ®Google Scholar
• Littman DR. (1998). Chemokine receptors: keys to AIDS pathogenesis? Cell 93:677–680.
   Google Scholar
• Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. (1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367–377.
   PubMed Web of Science ®Google Scholar
• Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Nall Acad Sci USA 95:14500–14505.
   PubMed Web of Science ®Google Scholar
• Michael NL, Chang G, Louie LG, Mascola JR, Don-dero D, Birx DL, Sheppard HW. (1997). The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 3: 338–340.
   PubMed Web of Science ®Google Scholar
• Misse D, Cerutti M, Noraz N, Jourdan P. Favero J, Devauchelle G, Yssel H, Taylor N, Veas F. (1999). A CD4-independent interaction of human immunodefi-ciency virus-1 gp120 with CXCR4 induces their coin-ternalization, cell signaling, and T-cell chemotaxis. Blood 93:2454–2462.
   PubMedGoogle Scholar
• Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. (2000). International union of pharmacol-ogy. XXII: nomenclature for chemokine receptors. Pharmacol Rev 52:145–176.
   Google Scholar
• Myers SJ, Wong LM, Charo IF. (1995). Signal trans-duction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J Biol Chem 270:5786–5792.
   Google Scholar
• Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638.
   PubMed Web of Science ®Google Scholar
• Nemerson Y. (1995). Tissue factor: then and now. Thromb Haemost 74:180–184.
   PubMed Web of Science ®Google Scholar
• Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. (1993). Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415–425.
   PubMed Web of Science ®Google Scholar
• Nieto M, Navarro F, Perez-Villar JJ, del Pozo MA, Gonzalez-Amaro R, Mellado M, Frade JM, Martinez AC, Lopez-Botet M, Sanchez-Madrid F. (1998). Roles of chemokines and receptor polarization in NK-target cell interactions. J Immunol 161:3330–3339.
   Google Scholar
• Ochensberger B, Tassera L, Bifrare D, Rihs S, Dahin- den CA. (1999). Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists. Eur J Immunol 29:11–22.
   PubMedGoogle Scholar
• Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. (2001). Detection of monocyte chemoattractant protein-1 receptor expression in experimental athero-sclerotic lesions: an autoradiographic study. Circula-tion 104:203–208.
   PubMedGoogle Scholar
• Owens GK. (1995). Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487–517.
   PubMed Web of Science ®Google Scholar
• Owens GK. (1991). Role of contractile agonists in growth regulation of vascular smooth muscle cells. Adv Exp Med Biol 308:71–79.
   Google Scholar
• Owens GK, Vernon SM, Madsen CS. (1996). Molecu-lar regulation of smooth muscle cell differentiation. J Hypertens Suppl 14:S55–S64.
   Google Scholar
• Passalaris JD, Sepkowitz KA, Glesby MJ. (2000). Coronary artery disease and human immunodeficien-cy virus infection. Clin Infect Dis 31:787–797.
   Google Scholar
• Paton P. Tabib A, Loire R, Tete R. (1993). Coronary artery lesions and human immunodeficiency virus in-fection. Res Virol 144:225–231.
   Google Scholar
• Popik W, Pitha PM. (2000). Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology 276:1–6.
   Google Scholar
• Porreca E, Di Febbo C, Reale M, Castellani ML, Bac-cante G, Barbacane R, Conti P. Cuccurullo F, Poggi A. (1997). Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res 34:58–65.
   PubMed Web of Science ®Google Scholar
• Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. (1996). Molecular cloning and functional characterization of a novel human CC chemokine re-ceptor (CCR5) for RANTES, MIP-lbeta, and MIP-lalpha. J Biol Chem 271:17161–17166.
   PubMed Web of Science ®Google Scholar
• Reidy MA, Fingerle J, Lindner V. (1992). Factors controlling the development of arterial lesions after injury. Circulation 86:11143–11146.
   Google Scholar
• Rollins BJ. (1997). Chemokines. Blood 90:909–928.
   PubMed Web of Science ®Google Scholar
• Roque M, Kim WJ, Gazdoin M, Malik A, Reis ED, Fallon JT, Badimon JJ, Charo IF, Taubman MB. (2002). CCR2 deficiency decreases intimal hyperpla-sia after arterial injury. Arterioscler Thromb Vasc Biol 22:554–559.
   PubMed Web of Science ®Google Scholar
• Ross R. (1999). Atherosclerosis is an inflammatory disease. Am Heart J 138:S419–S420.
   Google Scholar
• Ross R. (1995). Cell biology of atherosclerosis. Annu Rev Physiol 57:791–804.
   Google Scholar
• Ruffing N, Sullivan N, Sharmeen L, Sodroski J, Wu L. (1998). CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell Immunol 189:160–168.
   PubMed Web of Science ®Google Scholar
• Schall TJ, Bacon KB. (1994). Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6:865–873.
   PubMed Web of Science ®Google Scholar
• Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, Klotman ME, Taubman MB. (2001). HIV envelope gp120 activates human arterial smooth muscle cells. Proc Nall Acad Sci USA 98: 10142–10147.
   PubMed Web of Science ®Google Scholar
• Schecter AD, Calderon TM, Berman AB, McManus CM, Fallon JT, Rossikhina M, Zhao W, Christ G, Ber-man JW, Taubman MB. (2000). Human vascular smooth muscle cells possess functional CCR5. J Biol Chem 275:5466–5471.
   PubMed Web of Science ®Google Scholar
• Schecter AD, Rollins BJ, Zhang YJ, Charo IF, Fallon JT, Rossikhina M, Giesen PL, Nemerson Y, Taubman MB. (1997). Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem 272:28568–28573.
   PubMed Web of Science ®Google Scholar
• Sica A, Saccani A, Borsatti A, Power CA, Wells TN, Luini W, Polentarutti N, Sozzani S,Mantovani A. (1997). Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185:969–974.
   PubMed Web of Science ®Google Scholar
• Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, D'Amico G, Power CA, Wells TN, Gobbi M, Allavena P. Mantovani A. (1997). Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159:1993–2000.
   Google Scholar
• Tabib A, Leroux C, Momex JF, Loire R. (2000). Ac-celerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients. Coron Artery Dis 11:41–46.
   PubMed Web of Science ®Google Scholar
• Taubman MB, Fallon JT, Schecter AD, Giesen P. Mendlowitz M, Fyfe BS, Marmur JD,Nemerson Y. (1997). Tissue factor in the pathogenesis of athero-sclerosis. Thromb Haemost 78:200–204.
   PubMed Web of Science ®Google Scholar
• Taubman MB, Rollins BJ, Poon M, Marmur J, Green RS, Berk BC, Nadal-Ginard B. (1992). JE mRNA ac-cumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res 70:314–325.
   PubMed Web of Science ®Google Scholar
• Ullrich CK, Groopman JE, Ganju RK. (2000). HIV-1 gp120- and gp160-induced apoptosis in cultured en-dothelial cells is mediated by caspases. Blood 96: 1438–1442.
   Web of Science ®Google Scholar
• Valente AJ, Fowler SR, Sprague EA, Kelley JL, Suen-ram CA, Schwartz CJ. (1984). Initial characterization of a peripheral blood mononuclear cell chemoattrac-tant derived from cultured arterial smooth muscle cells. Am J Pathol 117:409–417.
   PubMed Web of Science ®Google Scholar
• Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kubler W, Kreuzer J. (2002). Monocyte chemoattrac-tant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differ-ential activation of nuclear factor-kappaB and acti-vator protein-1. Arterioscler Thromb Vasc Biol 22: 914–920.
   PubMed Web of Science ®Google Scholar
• Weber KS, Nelson PJ, Grone HJ, Weber C. (1999). Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085–2093.
   PubMed Web of Science ®Google Scholar
• Wysocki SJ, Zheng MH, Smith A, Lamawansa MD, Iacopetta BJ, Robertson TA, Papadimitriou JM, House AK, Norman PE. (1996). Monocyte chemoat-tractant protein-1 gene expression in injured pig ar- tery coincides with early appearance of infiltrating monocyte/macrophages. J Cell Biochem 62:303–313.
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. (1991). Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Nall Acad Sci USA 88:5252–5256.
   PubMed Web of Science ®Google Scholar